Abstract
A subset of the neutralizing anti-HIV antibodies recognize epitopes on the envelope protein gp120 of the human immunodeficiency virus. These epitopes are exposed during conformational changes when gp120 binds to its primary receptor CD4. Based on chemical modification of lysine and arginine residues followed by mass spectrometric analysis, we determined the epitope on gp120 recognized by the human monoclonal antibody 559/64-D, which was previously found to be specific for the CD4 binding domain. Twenty-four lysine and arginine residues in recombinant full-length glycosylated gp120 were characterized; the relative reactivities of two lysine residues and five arginine residues were affected by the binding of 559/64-D. The data show that the epitope is discontinuous and is located in the proximity of the CD4-binding site. Additionally, the reactivities of a residue that is located in the secondary receptor binding region and several residues distant from the CD4 binding site were also altered by Ab binding. These data suggest that binding of 559/64-D induced conformational changes which result in altered surface exposure of specific amino acids distant from the CD4-binding site. Consequently, binding of 559/64-D to gp120 affects not only the CD4-binding site, which is recognized as the epitope, but appears to have a global effect on surface exposed residues of the full-length glycosylated gp120.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Zolla-Pazner, S. Identifying Epitopes of HIV-1 that Induce Protective Antibodies. Nature Reviews Immunology 2004, 4(3), 199–210.
Poignard, P.; Klasse, P. J.; Sattentau, Q. J. Antibody Neutralization of HIV-1. Immunol. Today 1996, 17(5), 239–246.
Center, R. J.; Leapman, R. D.; Lebowitz, J.; Arthur, L. O.; Earl, P. L.; Moss, B. Oligomeric Structure of the Human Immunodeficiency Virus Type I Envelope Protein on the Virion Surface. J. Virol. 2002, 76(15), 7863–7867.
Dalgleish, A. G.; Beverley, P. C. L.; Clapham, P. R.; Crawford, D. H.; Greaves, M. F.; Weiss, R. A. The CD4 (T4) Antigen is an Essential Component of the Receptor for the AIDS Retrovirus. Nature 1984, 312(5996), 763–767.
Klatzmann, D.; Champagne, E.; Chamaret, S.; Gruest, J.; Guetard, D.; Hercend, T.; Gluckman, J. C.; Montagnier, L. Lymphocyte-T T4 Molecule Behaves as the Receptor for Human Retrovirus LAV. Nature 1984, 312(5996), 767–768.
Gagne, N. Demonstration of a Thermoreversible Gel for the Prevention of HIV and Herpes Transmission; Universite Laval: QC, Canada 2000; p. 111.
Zaitseva, M.; Peden, K.; Golding, H. HIV Coreceptors: Role of Structure, Post-Translational Modifications, and Internalization in Viral-Cell Fusion and as Targets for Entry Inhibitors. Biochim. Biophys. Acta-Biomembranes 2003, 1614(1), 51–61.
Starcich, B. R.; Hahn, B. H.; Shaw, G. M.; McNeely, P. D.; Modrow, S.; Wolf, H.; Parks, E. S.; Parks, W. P.; Josephs, S. F.; Gallo, R. C.; Wongstaal, F. Identification and Characterization of Conserved and Variable Regions in the Envelope Gene of HTLV-III LAV, the Retrovirus of AIDS. Cell 1986, 45(5), 637–648.
Kwong, P. D.; Wyatt, R.; Robinson, J.; Sweet, R. W.; Sodroski, J.; Hendrickson, W. A. Structure of an HIV gp120 Envelope Glycoprotein in Complex with the CD4 Receptor and a Neutralizing Human Antibody. Nature 1998, 393(6686), 648–659.
Leonard, C. K.; Spellman, M. W.; Riddle, L.; Harris, R. J.; Thomas, J. N.; Gregory, T. J. Assignment of Intrachain Disulfide Bonds and Characterization of Potential Glycosylation Sites of the Type-1 Recombinant Human-Immunodeficiency-Virus Envelope Glycoprotein (gp120) Expressed in Chinese Hamster Ovary Cells. J. Biol. Chem. 1990, 265(18), 10373–10382.
Cutalo, J. M.; Deterding, L. J.; Tomer, K. B. Characterization of Glycopeptides from HIV-I-SF2 gp120 by Liquid Chromatography Mass Spectrometry. J. Am. Soc. Mass Spectrom. 2004, 15(11), 1545–1555.
Zhu, X. G.; Borchers, C.; Bienstock, R. J.; Tomer, K. B. Mass Spectrometric Characterization of the Glycosylation Pattern of HIV-gp120 Expressed in CHO cells. Biochemistry 2000, 39(37), 11194–11204.
Bouma, P.; Leavitt, M.; Zhang, P. F.; Sidorov, I. A.; Dimitrov, D. S.; Quinnan, G. V. Multiple Interactions Across the Surface of the gp120 Core Structure Determine the Global Neutralization Resistance Phenotype of Human Immunodeficiency Virus Type 1. J. Virol. 2003, 77(14), 8061–8071.
Gorny, M. K.; Williams, C.; Volsky, B.; Revesz, K.; Cohen, S.; Polonis, V. R.; Honnen, W. J.; Kayman, S. C.; Krachmarov, C.; Pinter, A.; Zolla-Pazner, S. Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades. J. Virol. 2002, 76(18), 9035–9045.
Moore, J. P.; Sodroski, J. Antibody Cross-Competition Analysis of the Human Immunodeficiency Virus Type 1 gp120 Exterior Envelope Glycoprotein. J. Virol. 1996, 70(3), 1863–1872.
Nyambi, P. N.; Mbah, H. A.; Burda, S.; Williams, C.; Gorny, M. K.; Nadas, A.; Zolla-Pazner, S. Conserved and Exposed Epitopes on Intact, Native, Primary Human Immunodeficiency Virus Type 1 Virions of Group M. J. Virol. 2000, 74(15), 7096–7107.
Wyatt, R.; Sodroski, J.; The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens. Science 1998, 280(5371), 1884–1888.
Zwick, M. B.; Kelleher, R.; Jensen, R.; Labrijn, A. F.; Wang, M.; Quinnan, G. V.; Parren, P.; Burton, D. R. A Novel Human Antibody Against Human Immunodeficiency Virus Type 1 gp120 is V1, V2, and V3 Loop Dependent and Helps Delimit the Epitope of the Broadly Neutralizing Antibody Immunoglobulin G1 b12. J. Virol. 2003, 77(12), 6965–6978.
Zwick, M. B.; Parren, P.; Saphire, E. O.; Church, S.; Wang, M.; Scott, J. K.; Dawson, P. E.; Wilson, I. A.; Burton, D. R. Molecular Features of the Broadly Neutralizing Immunoglobulin G1 b12 Required for Recognition of Human Immunodeficiency Virus Type 1 gp120. J. Virol. 2003, 77(10), 5863–5876.
Wyatt, R.; Kwong, P. D.; Desjardins, E.; Sweet, R. W.; Robinson, J.; Hendrickson, W. A.; Sodroski, J. G. The Antigenic Structure of the HIV gp120 Envelope Glycoprotein. Nature 1998, 393(6686), 705–711.
Nunberg, J. H.; Follis, K. E.; Trahey, M.; LaCasse, R. A. Turning a corner on HIV neutralization? Microb. Infect. 2000, 2(2), 213–221.
Myszka, D. G.; Sweet, R. W.; Hensley, P.; Brigham-Burke, M.; Kwong, P. D.; Hendrickson, W. A.; Wyatt, R.; Sodroski, J.; Doyle, M. L. Energetics of the HIV gp120-CD4 Binding Reaction. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(16), 9026–9031.
Xiang, S. H.; Kwong, P. D.; Gupta, R.; Rizzuto, C. D.; Casper, D. J.; Wyatt, R.; Wang, L. P.; Hendrickson, W. A.; Doyle, M. L.; Sodroski, J. Mutagenic Stabilization and/or Disruption of a CD4-Bound State Reveals Distinct Conformations of the Human Immunodeficiency Virus Type 1 gp120 Envelope Glycoprotein. J. Virol. 2002, 76(19), 9888–9899.
Stricher, F.; Huang, C. C.; Descours, A.; Duquesnoy, S.; Combes, O.; Decker, J. M.; Do Kwon, Y.; Lusso, P.; Shaw, G. M.; Vita, C.; Kwong, P. D.; Martin, L. Combinatorial Optimization of a CD4-Mimetic Miniprotein and Cocrystal Structures with HIV-1 gp120 Envelope Glycoprotein. J. Mol. Biol. 2008, 382(2), 510–524.
Chen, L.; Kwon, Y. D.; Zhou, T. Q.; Wu, X. L.; O’Dell, S.; Cavacini, L.; Hessell, A. J.; Pancera, M.; Tang, M.; Xu, L.; Yang, Z. Y.; Zhang, M. Y.; Arthos, J.; Burton, D. R.; Dimitrov, D. S.; Nabel, G. J.; Posner, M. R.; Sodroski, J.; Wyatt, R.; Mascola, J. R.; Kwong, P. D. Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120. Science 2009, 326(5956), 1123–1127.
Pan, Y. P.; Ma, B. Y.; Keskin, O.; Nussinov, R. Characterization of the Conformational State and Flexibility of HIV-1 Glycoprotein gp120 Core Domain. J. Biol. Chem. 2004, 279(29), 30523–30530.
Chen, B.; Vogan, E. M.; Gong, H. Y.; Skehel, J. J.; Wiley, D. C.; Harrison, S. C. Structure of an Unliganded Simian Immunodeficiency Virus gp120 Core. Nature 2005, 433(7028), 834–841.
McKeating, J. A.; Thali, M.; Furman, C.; Karwowska, S.; Gorny, M. K.; Cordell, J.; Zolla-Pazner, S.; Sodroski, J.; Weiss, R. A. Amino Acid Residues of the Human Immunodeficiency Virus Type I gp120Ccritical for the Binding of Rat and Human Neutralizing Antibodies that Block the gp120-sCD4 Interaction. Virology 1992, 190(1), 134–142.
Karwowska, S.; Gorny, M. K.; Buchbinder, A.; Gianakakos, V.; Williams, C.; Fuerst, T.; Zolla-Pazner, S. Production of Human Monoclonal Antibodies Specific for Conformational and Linear Non-V3 Epitopes of gp120. AIDS Res. Hum. Retrovir. 1992, 8(6), 1099–1106.
Chien, P. C.; Cohen, S.; Tuen, M.; Arthos, J.; Chen, P. D.; Patel, S.; Hioe, C. E. Human Immunodeficiency Virus Type 1 Evades T-Helper Responses by Exploiting Antibodies that Suppress Antigen Processing. J. Virol. 2004, 78(14), 7645–7652.
Li, H. L.; Chien, P. C.; Tuen, M.; Visciano, M. L.; Cohen, S.; Blais, S.; Xu, C. F.; Zhang, H. T.; Hioe, C. E. Identification of an N-Linked Glycosylation in the C4 Region of HIV-1 Envelope gp120 that is Critical for Recognition of Neighboring CD4 T Cell Epitopes. J. Immunol. 2008, 180(6), 4011–4021.
Li, H. L.; Xu, C. F.; Blais, S.; Wan, Q.; Zhang, H. T.; Landry, S. J.; Hioe, C. E. Proximal Glycans Outside of the Epitopes Regulate the Presentation of HIV-1 Envelope gp120 Helper Epitopes. J. Immunol. 2009, 182(10), 6369–6378.
Visciano, M. L.; Tuen, M.; Gorny, M. K.; Hioe, C. E. In Vivo Alteration of Humoral Responses to HIV-1 Envelope Glycoprotein gp120 by Antibodies to the CD4-Binding Site of gp120. Virology 2008, 372(2), 409–420.
Nandi, A.; Lavine, C. L.; Wang, P. C.; Lipchina, I.; Goepfert, P. A.; Shaw, G. M.; Tomaras, G. D.; Montefiori, D. C.; Haynes, B. F.; Easterbrook, P.; Robinson, J. E.; Sodroski, J. G.; Yang, X. Z.; and the NIAID Center for HIV/AIDS Vaccine Immunology. Epitopes for Broad and Potent Neutralizing Antibody Responses During Chronic Infection with Human Immunodeficiency Virus Type 1. Virology 2010, 396(2), 339–348.
Stamatatos, L.; Chengmayer, C. Structural Modulations of the Envelope gp120 Glycoprotein of Human-Immunodeficiency-Virus Type-1 Upon Oligomerization and Differential V3 Loop Epitope Exposure of Isolates Displaying Distinct Tropism Upon Virion-Soluble Receptor-Binding. J. Virol. 1995, 69(10), 6191–6198.
Wilkinson, R. A.; Piscitelli, C.; Teintze, M.; Cavacini, L. A.; Posner, M. R.; Lawrence, C. M.; Structure of the Fab Fragment of F105, a Broadly Reactive Anti-Human Immunodeficiency Virus (HIV) Antibody that Recognizes the CD4 Binding Site of HIV Type 1 gp120. J. Virol. 2005, 79(20), 13060–13069.
Glocker, M. O.; Borchers, C.; Fiedler, W.; Suckau, D.; Przybylski, M. Molecular Characterization of Surface-Topology in Protein Tertiary Structures by Aminoacylation and Mass-Spectrometric Peptide Mapping. Bioconj. Chem. 1994, 5(6), 583–590.
Hochleitner, E. O.; Borchers, C.; Parker, C.; Bienstock, R. J.; Tomer, K. B. Characterization of a Discontinuous Epitope of the Human Immunodeficiency Virus (HIV) Core Protein p24 by Epitope Excision and Differential Chemical Modification Followed by Mass Spectrometric Peptide Mapping Analysis. Protein Sci. 2000, 9(3), 487–496.
Steiner, R. F.; Albaugh, S.; Fenselau, C.; Murphy, C.; Vestling, M. A. Mass-Spectrometry Method for Mapping the Interface Topography of Interacting Proteins, Illustrated by the Melittin-Calmodulin System. Anal. Biochem. 1991, 196(1), 120–125.
Suckau, D.; Mak, M.; Przybylski, M. Protein Surface Topology-Probing by Selective Chemical Modification and Mass-Spectrometric Peptide Mapping. Proc. Natl. Acad. Sci. U.S.A. 1992, 89(12), 5630–5634.
Hager-Braun, C.; Tomer, K. B. Characterization of the Tertiary Structure of Soluble CD4 Bound to Glycosylated Full-Length HIVgp120 by Chemical Modification of Arginine Residues and Mass Spectrometric Analysis. Biochemistry 2002, 41(6), 1759–1766.
Wood, T. D.; Guan, Z. Q.; Borders, C. L.; Chen, L. H.; Kenyon, G. L.; McLafferty, F. W. Creatine Kinase: Essential Arginine Residues at the Nucleotide Binding Site Identified by Chemical Modification and High-Resolution Tandem Mass Spectrometry. Proc. Natl. Acad. Sci. U.S.A. 1998, 95(7), 3362–3365.
Korber, B. T.; Foley, B. T.; Kuiken, C. L.; Pillai, S. K.; Sodroski, J. G. Numbering Positions in HIV Relative to HXB2CG. 1998 [cited 1998; available from: http://www.hiv.lanl.gov/content/sequence/HIV/COMPENDIUM/1998/III/HXB2.pdf
Hager-Braun, C.; Katinger, H.; Tomer, K. B. The HIV-Neutralizing Monoclonal Antibody 4E10 Recognizes N-Terminal Sequences on the Native Antigen. J. Immunol. 2006, 176(12), 7471–7481.
Kwong, P. D.; Wyatt, R.; Majeed, S.; Robinson, J.; Sweet, R. W.; Sodroski, J.; Hendrickson, W. A. Structures of HIV-1 gp120 Envelope Glycoproteins from Laboratory-Adapted and Primary Isolates. Structure 2000, 8(12), 1329–1339.
Parker, C. E.; Deterding, L. J.; Hager-Braun, C.; Binley, J. M.; Schulke, N.; Katinger, H.; Moore, J. P.; Tomer, K. B. Fine Definition of the Epitope on the gp41 Glycoprotein of Human Immunodeficiency Virus Type 1 for the Neutralizing Monoclonal Antibody 2F5. J. Virol. 2001, 75(22), 10906–10911.
Zwick, M. B.; Labrijn, A. F.; Wang, M.; Spenlehauer, C.; Saphire, E. O.; Binley, J. M.; Moore, J. P.; Stiegler, G.; Katinger, H.; Burton, D. R.; Parren, P. Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41. J. Virol. 2001, 75(22), 10892–10905.
Hobbs, C. A.; Deterding, L. J.; Perera, L.; Bobay, B. G.; Thompson, R. J.; Darden, T. A.; Cavanagh, J.; Tomer, K. B. Structural Characterization of the Conformational Change in Calbindin-D-28k upon Calcium Binding Using Differential Surface Modification Analyzed by Mass Spectrometry. Biochemistry 2009, 48(36), 8603–8614.
Iacob, R. E.; Keck, Z.; Olson, O.; Foung, S. K. H.; Tomer, K. B. Structural Elucidation of Critical Residues Involved in Binding of Human Monoclonal Antibodies to Hepatitis C Virus E2 Envelope Glycoprotein. Biochim. Biophys. Acta-Proteins and Proteomics 2008, 1784(3), 530–542.
Feng, Y.; Broder, C. C.; Kennedy, P. E.; Berger, E. A. HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor. Science 1996, 272(5263), 872–877.
Lusso, P.; HIV and the Chemokine System: 10 Years Later. EMBO J. 2006, 25(3), 447–456.
Trkola, A.; Dragic, T.; Arthos, J.; Binley, J. M.; Olson, W. C.; Allaway, G. P.; ChengMayer, C.; Robinson, J.; Maddon, P. J.; Moore, J. P. CD4-Dependent, Antibody-Sensitive Interactions Between HIV-1 and Its Coreceptor CCR-5. Nature 1996, 384(6605), 184–187.
Wu, L. J.; Gerard, N. P.; Wyatt, R.; Choe, H.; Parolin, C.; Ruffing, N.; Borsetti, A.; Cardoso, A. A.; Desjardin, E.; Newman, W.; Gerard, C.; Sodroski, J. CD4-Induced Interaction of Primary HIV-1 gp120 Glycoproteins with the Chemokine Receptor CCR-5. Nature 1996, 384(6605), 179–183.
Sanchezpescador, R.; Power, M. D.; Barr, P. J.; Steimer, K. S.; Stempien, M. M.; Brownshimer, S. L.; Gee, W. W.; Renard, A.; Randolph, A.; Levy, J. A.; Dina, D.; Luciw, P. A. Nucleotide Sequence and Expression of an AIDS-Associated Retrovirus (ARV-2). Science 1985, 227(4686), 484–492.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Hager-Braun, C., Hochleitner, E.O., Gorny, M.K. et al. Characterization of a discontinuous epitope of the HIV envelope protein gp120 recognized by a human monoclonal antibody using chemical modification and mass spectrometric analysis. J Am Soc Mass Spectrom 21, 1687–1698 (2010). https://doi.org/10.1016/j.jasms.2010.03.031
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.jasms.2010.03.031